Clinical Trials 162 Views Ultimovacs completes patient recruitment in Phase II trial Malin Otmani January 23, 2023 Ultimovacs has announced the completed …
Clinical Trials 470 Views IRLAB announces Phase IIb results Malin Otmani January 18, 2023 IRLAB Therapeutics has announced the …
Clinical Trials 1511 Views Cemiplimab to replace pembrolizumab in Ultimovacs trial Malin Otmani December 20, 2022 Ultimovacs has announced that cemiplimab …
Clinical Trials 2408 Views Mendus reports positive trial results Malin Otmani December 14, 2022 Mendus has presented survival data …
Clinical Trials 2392 Views IRLAB reports Last Patient Last Visit in Phase IIb trial Malin Otmani December 14, 2022 IRLAB Therapeutics has announced that …
Clinical Trials 1694 Views Spago Nanomedical initiates clinical trial in endometriosis Malin Otmani December 5, 2022 Spago Nanomedical has received regulatory …
Clinical Trials 1850 Views Evaxion announces Phase 1/2a results Malin Otmani November 18, 2022 Evaxion Biotech has announced clinical …
Clinical Trials 2069 Views EpiEndo initiates Phase 2a trial Malin Otmani November 15, 2022 EpiEndo Pharmaceuticals has received regulatory …
Clinical Trials 1777 Views Affibody’s partner announces positive Phase I results Malin Otmani November 9, 2022 Affibody’s licensee Rallybio Corporation has …
Clinical Trials 2581 Views Cantargia reports new promising data Malin Otmani November 8, 2022 Cantargia has reported new data …
Clinical Trials 1302 Views Gesynta Pharma prepares Phase II study of GS-248 in endometriosis Malin Otmani November 1, 2022 Gesynta Pharma has announced the …
Clinical Trials 623 Views First patient randomized in Ultimovacs’ LUNGVAC trial Malin Otmani October 26, 2022 Ultimovacs has announced that the …
Clinical Trials 578 Views BerGenBio initiates Phase 1b/2a trial Malin Otmani October 14, 2022 BerGenBio has announced the initiation …
Clinical Trials 572 Views Nykode announces positive Phase 1/2 results Malin Otmani October 14, 2022 Nykode Therapeutics has announced clinical …
Clinical Trials 497 Views First US patient dosed in TILT’s Phase I study Malin Otmani October 11, 2022 TILT Biotherapeutics has announced that …
Clinical Trials 353 Views Orexo announces positive Phase I data Malin Otmani October 11, 2022 Orexo has announced positive results …